Crosstalk between red blood cells and the immune system and its impact on atherosclerosis

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Buttari, Brigitta ^a   Profumo, Elisabetta ^a   Riganò, Rachele ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD47 ANTIGEN; CYTOKINE; GLYCOPHORIN A; LIPOPOLYSACCHARIDE; MEMBRANE ANTIGEN; PHOSPHATIDYLSERINE; SCAVENGER; CD47 PROTEIN, HUMAN; GLYCOPHORIN;

ADAPTIVE IMMUNITY; APOPTOSIS; ATHEROSCLEROSIS; CELL MATURATION; CYTOKINE RELEASE; DENDRITIC CELL; ERYTHROCYTE; ERYTHROCYTE PRESERVATION; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MACROPHAGE; MOLECULAR INTERACTION; MOLECULE; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REVIEW; SENESCENCE; T LYMPHOCYTE; CELL PROLIFERATION; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY;

ANTIGENS, CD47; ATHEROSCLEROSIS; CELL PROLIFERATION; ERYTHROCYTES; GLYCOPHORIN; HUMANS; IMMUNE SYSTEM; INFLAMMATION; OXIDATIVE STRESS; T-LYMPHOCYTES;

EID: 84924073380     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/616834     Document Type: Review

References (96)

1. F. A. Arosa, C. F. Pereira, and A. M. Fonseca, "Red blood cells as modulators to T cell growth and survival," Current Pharmaceutical Design, vol. 10, no. 2, pp. 191-201, 2004.
2. K. Schäkel, M. von Kietzell, A. Hansel et al., "Human 6- sulfo LacNAc-expressing dendritic cells are principal producers of early interleukin-12 and are controlled by erythrocytes," Immunity, vol. 24, no. 6, pp. 767-777, 2006.
3. R. Businaro, A. Tagliani, B. Buttari et al., "Cellular and molecular players in the atherosclerotic plaque progression," Annals of the New York Academy of Sciences, vol. 1262, no. 1, pp. 134-141, 2012.
4. G. K. Hansson and A. Hermansson, "The immune system in atherosclerosis," Nature Immunology, vol. 12, no. 3, pp. 204-212, 2011.
5. K. J. Woollard and F. Geissmann, "Monocytes in atherosclerosis: subsets and functions," Nature Reviews Cardiology, vol. 7, no. 2, pp. 77-86, 2010.
6. R. Businaro, M. Digregorio, R. Rigano et al., "Morphological analysis of cell subpopulations within carotid atherosclerotic plaques," Italian Journal of Anatomy and Embryology, vol. 110, no. 2, pp. 109-115, 2005.
7. A. P. Levy and P. R. Moreno, "Intraplaque hemorrhage," Current Molecular Medicine, vol. 6, no. 5, pp. 479-488, 2006.
8. F. D. Kolodgie, H. K. Gold, A. P. Burke et al., "Intraplaque hemorrhage and progression of coronary atheroma," The New England Journal of Medicine, vol. 349, no. 24, pp. 2316-2325, 2003.
9. P. Muda, P. Kampus, M. Zilmer et al., "Homocysteine and red blood cell glutathione as indices for middle-aged untreated essential hypertension patients," Journal ofHypertension, vol. 21, no. 12, pp. 2329-2333, 2003.
10. E. Pytel, M. Olszewska-Banaszczyk, M. Koter-Michalak, and M. Broncel, "Increased oxidative stress and decreased membrane fluidity in erythrocytes of CAD patients," Biochemistry and Cell Biology, vol. 91, no. 5, pp. 315-318, 2013.
11. T. Anuk, E. B. Assayag, R. Rotstein et al., "Prognostic implications of admission inflammatory profile in acute ischemic neurological events," Acta Neurologica Scandinavica, vol. 106, no. 4, pp. 196-199, 2002.
12. B. N. Y. Setty, M. J. Stuart, C. Dampier, D. Brodecki, and J. L. Allen, "Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology," The Lancet, vol. 362, no. 9394, pp. 1450-1455, 2003.
13. R. F. Antunes, C. Brandão,M. Maia, and F. A. Arosa, "Red blood cells release factors with growth and survival bioactivities for normal and leukemic T cells," Immunology and Cell Biology, vol. 89, no. 1, pp. 111-121, 2011.
14. A. M. Fonseca, G. Porto, K. Uchida, and F. A. Arosa, "Red blood cells inhibit activation-induced cell death and oxidative stress in human peripheral blood T lymphocytes," Blood, vol. 97, no. 10, pp. 3152-3160, 2001.
15. R. J. Melder, J. Yuan, L. L. Munn, and R. K. Jain, "Erythrocytes enhance lymphocyte rolling and arrest in vivo," Microvascular Research, vol. 59, no. 2, pp. 316-322, 2000.
16. B. Buttari, E. Profumo, B. Cuccu et al., "Erythrocytes from patients with carotid atherosclerosis fail to control dendritic cell maturation," International Journal of Cardiology, vol. 155, no. 3, pp. 484-486, 2012.
17. E. Profumo, B. Buttari, L. Petrone et al., "Redox imbalance of red blood cells impacts T lymphocyte homeostasis: implication in carotid atherosclerosis," Thrombosis and Haemostasis, vol. 106, no. 6, pp. 1117-1126, 2011.
18. M. Minetti, L. Agati, and W. Malorni, "The microenvironment can shift erythrocytes from a friendly to a harmful behavior: pathogenetic implications for vascular diseases," Cardiovascular Research, vol. 75, no. 1, pp. 21-28, 2007.
19. M. Comporti, C. Signorini, G. Buonocore, and L. Ciccoli, "Iron release, oxidative stress and erythrocyte ageing," Free Radical Biology and Medicine, vol. 32, no. 7, pp. 568-576, 2002.
20. C. Signorini, M. Ferrali, L. Ciccoli, L. Sugherini, A. Magnani, and M. Comporti, "Iron release, membrane protein oxidation and erythrocyte ageing," FEBS Letters, vol. 362, pp. 165-170, 1995.
21. F. Arslan, M. B. Smeets, B. Buttari et al., "Lack of haptoglobin results in unbalanced vEGFα/angiopoietin-1 expression, Intramural hemorrhage and impaired wound healing after myocardial infarction," Journal of Molecular and Cellular Cardiology, vol. 56, no. 1, pp. 116-128, 2013.
22. B. Buttari, E. Profumo, R. Businaro et al., "Oxidized haemoglobin-driven endothelial dysfunction and immune cell activation: novel therapeutic targets for atherosclerosis," Current Medicinal Chemistry, vol. 20, no. 37, pp. 4806-4814, 2013.
23. B. Buttari, E. Profumo, C. di Cristofano et al., "Haemoglobin triggers chemotaxis of human monocyte-derived dendritic cells: possible role in atherosclerotic lesion instability," Atherosclerosis, vol. 215, no. 2, pp. 316-322, 2011.
24. R. P. Rother, L. Bell, P. Hillmen, and M. T. Gladwin, "The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease," The Journal of the American Medical Association, vol. 293, no. 13, pp. 1653-1662, 2005.
25. G. Silva, V. Jeney, Â. Chora, R. Larsen, J. Balla, and M. P. Soares, "Oxidized hemoglobin is an endogenous proinflammatory agonist that targets vascular endothelial cells," The Journal of Biological Chemistry, vol. 284, no. 43, pp. 29582-29595, 2009.
26. P.W. Buehler, B. Abraham, F. vallelian et al., "Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin fromperoxidativemodification," Blood, vol. 113, no. 11, pp. 2578-2586, 2009.
27. N. Leitinger, "Oxidized phospholipids as triggers of inflammation in atherosclerosis,"Molecular Nutrition and Food Research, vol. 49, no. 11, pp. 1063-1071, 2005.
28. G. Leonarduzzi, E. Chiarpotto, F. Biasi, and G. Poli, "4- Hydroxynonenal and cholesterol oxidation products in atherosclerosis," Molecular Nutrition and Food Research, vol. 49, no. 11, pp. 1044-1049, 2005.
29. J.H. Crawford, B. K. Chacko, C. G. Kevil, and R. P. Patel, "The red blood cell and vascular function in health and disease," Antioxidants & Redox Signaling, vol. 6, no. 6, pp. 992-999, 2004.
30. M. M. B. Kay, G. J. C. G. M. Bosman, G. J. Johnson, and A. H. Beth, "Band-3 polymers and aggregates, and hemoglobin precipitates in red cell aging," Blood Cells, vol. 14, no. 1, pp. 275-289, 1988.
31. A. Pantaleo, G. Giribaldi, F. Mannu, P. Arese, and F. Turrini, "Naturally occurring anti-band 3 antibodies and red blood cell removal under physiological and pathological conditions," Autoimmunity Reviews, vol. 7, no. 6, pp. 457-462, 2008.
32. L. M. Snyder, F. Garver, S. C. Liu, L. Leb, J. Trainor, and N. L. Fortier, "Demonstration of haemoglobin associated with isolated, purified spectrin from senescent human red cells," British Journal of Haematology, vol. 61, no. 3, pp. 415-419, 1985.
33. L. M. Snyder, L. Leb, J. Piotrowski, N. Sauberman, S. C. Liu, and N. L. Fortier, "Irreversible spectrin-haemoglobin crosslinking in vivo: a marker for red cell senescence," British Journal of Haematology, vol. 53, no. 3, pp. 379-384, 1983.
34. H. U. Lutz and J. Fehr, "Total sialic acid content of glycophorins during senescence of human red blood cells," The Journal of Biological Chemistry, vol. 254, no. 22, pp. 11177-11180, 1979.
35. F. E. Boas, L. Forman, and E. Beutler, "Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia," Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 6, pp. 3077-3081, 1998.
36. T.-Y. Mao, L.-L. Fu, and J.-S. Wang, "Hypoxic exercise training causes erythrocyte senescence and rheological dysfunction by depressed Gardos channel activity," Journal of Applied Physiology, vol. 111, no. 2, pp. 382-391, 2011.
37. G. J. C. G. M. Bosman, E. Lasonder, M. Luten et al., "The proteomeof red cellmembranes and vesicles during storage in blood bank conditions," Transfusion, vol. 48, no. 5, pp. 827-835, 2008.
38. A. Stewart, S. Urbaniak, M. Turner, and H. Bessos, "The application of a new quantitative assay for the monitoring of integrin-associated protein CD47 on red blood cells during storage and comparison with the expression of CD47 and phosphatidylserine with flow cytometry," Transfusion, vol. 45, no. 9, pp. 1496-1503, 2005.
39. R. L. Sparrow, G. Healey, K. A. Patton, and M. F. veale, "Red blood cell age determines the impact of storage and leukocyte burden on cell adhesion molecules, glycophorin A and the release of annexin v," Transfusion and Apheresis Science, vol. 34, no. 1, pp. 15-23, 2006.
40. A. B. Zimrin and J. R. Hess, "Current issues relating to the transfusion of stored red blood cells," vox Sanguinis, vol. 96, no. 2, pp. 93-103, 2009.
41. C. F. Hogman and H. T. Meryman, "Storage parameters affecting red blood cell survival and function after transfusion," Transfusion Medicine Reviews, vol. 13, no. 4, pp. 275-296, 1999.
42. A. Giovannetti, L. Gambardella,D. Pietraforte et al., "Red blood cell alterations in systemic sclerosis: a pilot study," Cellular Physiology and Biochemistry, vol. 30, no. 2, pp. 418-427, 2012.
43. E. Straface, L. Gambardella, A. Mattatelli et al., "The red blood cell as a gender-associated biomarker in metabolic syndrome: a pilot study," International Journal of Cell Biology, vol. 2011, Article ID 204157, 7 pages, 2011.
44. E. Ingelsson, M. J. Pencina, G. H. Tofler et al., "Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes inmetabolic risk factors: the Framingham Offspring Study," Circulation, vol. 116, no. 9, pp. 984-992, 2007.
45. D. Poli, E. Antonucci, E. Grifoni, R. Abbate, G. F. Gensini, and D. Prisco, "Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment," Thrombosis and Haemostasis, vol. 101, no. 5, pp. 938-942, 2009.
46. D. Konukoʇlu, G. D. Kemerli, T. Sabuncu, and H. H. Hatemi, "Protein carbonyl content in erythrocyte membranes in type 2 diabetic patients," Hormone and Metabolic Research, vol. 34, no. 7, pp. 367-370, 2002.
47. V. Yelinova, Y. Glazachev, V. Khramtsov, L. Kudryashova, V. Rykova, and R. Salganik, "Studies of human and rat blood under oxidative stress: changes in plasma thiol level, antioxidant enzyme activity, protein carbonyl content, and fluidity of erythrocyte membrane," Biochemical and Biophysical Research Communications, vol. 221, no. 2, pp. 300-303, 1996.
48. N. S. Mangalmurti, S. Chatterjee, G. Cheng et al., "Advanced glycation end products on stored red blood cells increase endothelial reactive oxygen species generation through interaction with receptor for advanced glycation end products," Transfusion, vol. 50, no. 11, pp. 2353-2361, 2010.
49. A.-M. Schmidt, M. Hofmann, A. Taguchi, S. D. Yan, and D. M. Stern, "RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation," Seminars inThrombosis and Hemostasis, vol. 26, no. 5, pp. 485-493, 2000.
50. B. Buttari, E. Profumo, A. Capozzi et al., "Advanced glycation end products of human β 2 glycoprotein Imodulate the maturation and function of DCs," Blood, vol. 117, no. 23, pp. 6152-6161, 2011.
51. B. Buttari, E. Profumo, F. Facchiano et al., "Resveratrol prevents dendritic cellmaturation in response to advanced glycation end products," Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 574029, 12 pages, 2013.
52. A. M. Schmidt and D. Stern, "Atherosclerosis and diabetes: the RAGE connection," Current Atherosclerosis Reports, vol. 2, no. 5, pp. 430-436, 2000.
53. M. Ghashghaeinia, J. C. A. Cluitmans, A. Akel et al., "The impact of erythrocyte age on eryptosis," British Journal of Haematology, vol. 157, no. 5, pp. 606-614, 2012.
54. M. H. Antonelou, A. G. Kriebardis, K. E. Stamoulis, E. Economou- Petersen, L. H. Margaritis, and I. S. Papassideri, "Red blood cell aging markers during storage in citrate-phosphatedextrose- saline-adenine-glucose-mannitol," Transfusion, vol. 50, no. 2, pp. 376-389, 2010.
55. R. B. Ami, G. Barshtein, D. Zeltser et al., "Parameters of red blood cell aggregation as correlates of the inflammatory state," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 280, no. 5, pp. H1982-H1988, 2001.
56. S. Berliner, O. Rogowski, S. Aharonov et al., "Erythrocyte adhesiveness/aggregation: a novel biomarker for the detection of low-grade internal inflammation in individuals with atherothrombotic risk factors and proven vascular disease," American Heart Journal, vol. 149, no. 2, pp. 260-267, 2005.
57. R. E. Mebius and G. Kraal, "Structure and function of the spleen," Nature Reviews Immunology, vol. 5, no. 8, pp. 606-616, 2005.
58. Z. Mallat, H. Ait-Oufella, and A. Tedgui, "Regulatory TCell Immunity in atherosclerosis," Trends in Cardiovascular Medicine, vol. 17, no. 4, pp. 113-118, 2007.
59. B. Osterud and E. Bjorklid, "Role of monocytes in atherogenesis," Physiological Reviews, vol. 83, no. 4, pp. 1069-1112, 2003.
60. S. Ranjit and L. Dazhu, "Potential role of dendritic cells for progression of atherosclerotic lesions," Postgraduate Medical Journal, vol. 82, no. 971, pp. 573-575, 2006.
61. A. Yilmaz, M. Lochno, F. Traeg et al., "Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques," Atherosclerosis, vol. 176, no. 1, pp. 101-110, 2004.
62. R. M. Steinman, "The dendritic cell system and its role in immunogenicity,"Annual Reviewof Immunology, vol. 9, pp. 271-296, 1991.
63. R. M. Steinman, "The control of immunity and tolerance by dendritic cells," Pathologie Biologie, vol. 51, no. 2, pp. 59-60, 2003.
64. H. Ueno, E. Klechevsky, R. Morita et al., "Dendritic cell subsets in health and disease," Immunological Reviews, vol. 219, no. 1,pp. 118-142, 2007.
65. P. Matarrese, E. Straface, D. Pietraforte et al., "Peroxynitrite induces senescence and apoptosis of red blood cells through the activation of aspartyl and cysteinyl proteases," FASEB Journal, vol. 19, no. 3, pp. 416-418, 2005.
66. D. Pietraforte, P. Matarrese, E. Straface et al., "Two different pathways are involved in peroxynitrite-induced senescence and apoptosis of human erythrocytes," Free Radical Biology and Medicine, vol. 42, no. 2, pp. 202-214, 2007.
67. S. Yedgar, T. Hovav, and G. Barshtein, "Red blood cell intercellular interactions in oxidative stress states," ClinicalHemorheology and Microcirculation, vol. 21, no. 3-4, pp. 189-193, 1999.
68. B. Buttari, E. Profumo, L. Segoni et al., "Resveratrol counteracts inflammation in human M1 and M2 macrophages upon challenge with 7-oxo-cholesterol: potential therapeutic implications in atherosclerosis," Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID257543, 12 pages, 2014.
69. B. Buttari, L. Segoni, E. Profumo et al., "7-Oxo-cholesterol potentiates pro-inflammatory signaling in human M1 and M2 macrophages," Biochemical Pharmacology, vol. 86, no. 1, pp. 130-137, 2013.
70. D. Z. de Back, E. B. Kostova, M. van Kraaij, T. K. van den Berg, and R. van Bruggen, "Of macrophages and red blood cells; A complex love story," Frontiers in Physiology, vol. 5, article9, 2014.
71. K. S. Lang, P. A. Lang, C. Bauer et al., "Mechanisms of suicidal erythrocyte death," Cellular Physiology and Biochemistry, vol. 15, no. 5, pp. 195-202, 2005.
72. P. Arese, F. Turrini, and E. Schwarzer, "Band 3/complementmediated recognition and removal of normally senescent and pathological human erythrocytes," Cellular Physiology and Biochemistry, vol. 16, no. 4-6, pp. 133-146, 2005.
73. P. Burger, P. Hilarius-Stokman,D. De Korte, T. K. vanDen Berg, and R. van Bruggen, "CD47 functions as a molecular switch for erythrocyte phagocytosis," Blood, vol. 119, no. 23, pp. 5512-5521, 2012.
74. M. Kay, "Immunoregulation of cellular life span," Annals of the New York Academy of Sciences, vol. 1057, pp. 85-111, 2005.
75. H. U. Lutz, "Innate immune and non-immune mediators of erythrocyte clearance," Cellular and Molecular Biology (Noisyle- Grand), vol. 50, no. 2, pp. 107-116, 2004.
76. R. virmani, F. D. Kolodgie, A. P. Burke et al., "Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage," Arteriosclerosis,Thrombosis, and vascular Biology, vol. 25, no. 10, pp. 2054-2061, 2005.
77. A. E. Morelli, A. T. Larregina, W. J. Shufesky et al., "Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production," Blood, vol. 101, no. 2,pp. 611-620, 2003.
78. A. V. Finn and J. Narula, "Intraplaque hemorrhage: most dangerous is the wound that bleedeth inwardly," JACC: Cardiovascular Imaging, vol. 5, pp. 856-858, 2012.
79. K. Yazdanbakhsh, W. Bao, and H. Zhong, "Immunoregulatory effects of stored red blood cells," Hematology/the Education Program of the American Society of Hematology, vol. 2011, pp. 466-469, 2011.
80. D. M. Mosser and J. P. Edwards, "Exploring the full spectrum of macrophage activation," Nature Reviews Immunology, vol. 8, no. 12, pp. 958-969, 2008.
81. E. A. Hod,N. Zhang, S. A. Sokol et al., "Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation," Blood, vol. 115, no. 21, pp. 4284-4292, 2010.
82. F. L. A. Willekens, J. M. Werre, J. K. Kruijt et al., "Liver Kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger receptors," Blood, vol. 105, no. 5, pp. 2141-2145, 2005.
83. L. L. Munn, R. J. Melder, and R. K. Jain, "Role of erythrocytes in leukocyte-endothelial interactions: mathematical model and experimental validation," Biophysical Journal, vol. 71, no. 1, pp. 466-478, 1996.
84. Y. Kalechman, S. Herman, U. Gafter, and B. Sredni, "Enhancing effects of autologous erythrocytes on human or mouse cytokine secretion and IL-2R expression," Cellular Immunology, vol. 148, no. 1, pp. 114-129, 1993.
85. G. virella, M. T. Rugeles, B. Hyman et al., "The interaction of CD2with its LFA-3 ligand expressed by autologous erythrocytes results in enhancement of B cell responses," Cellular Immunology, vol. 116, no. 2, pp. 308-319, 1988.
86. S. Taleb, A. Tedgui, and Z. Mallat, "Adaptive T cell immune responses and atherogenesis," Current Opinion in Pharmacology, vol. 10, no. 2, pp. 197-202, 2010.
87. A. Tedgui and Z. Mallat, "Cytokines in atherosclerosis: pathogenic and regulatory pathways," Physiological Reviews, vol. 86, no. 2, pp. 515-581, 2006.
88. S. Sadallah, C. Eken, and J. A. Schifferli, "Erythrocyte-derived ectosomes have immunosuppressive properties," Journal of Leukocyte Biology, vol. 84, no. 5, pp. 1316-1325, 2008.
89. M. Schiller,M. Parcina, P. Heyder et al., "Inductionof type I IFN is a physiological immune reaction to apoptotic cell-derived membrane microparticles,"The Journal of Immunology, vol. 189, no. 4, pp. 1747-1756, 2012.
90. D. B. Kim-Shapiro, J. Lee, and M. T. Gladwin, "Storage lesion: role of red blood cell breakdown," Transfusion, vol. 51, no. 4, pp. 844-851, 2011.
91. W. Jy, M. Ricci, S. Shariatmadar,O. Gomez-Marin, L.H. Horstman, and Y. S. Ahn, "Microparticles in stored red blood cells as potential mediators of transfusion complications," Transfusion, vol. 51, no. 4, pp. 886-893, 2011.
92. A. Danesh,H. C. Inglis,R.P. Jackmanet al., "Exosomes fromred blood cell units bind tomonocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro," Blood, vol. 123, no. 5, pp. 687-696, 2014.
93. A. Tedgui and Z. Mallat, "Apoptosis as a determinant of atherothrombosis," Thrombosis and Haemostasis, vol. 86, no. 1, pp. 420-426, 2001.
94. S. Björkerud and B. Björkerud, "Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability," The American Journal of Pathology, vol. 149, no. 2, pp. 367-380, 1996.
95. M. M. Kockx and M.W. M. Knaapen, "The role of apoptosis in vascular disease," The Journal of Pathology, vol. 190, no. 3, pp. 267-280, 2000.
96. J.H. Crawford, B. K. Chacko, C. G. Kevil, and R. P. Patel, "The red blood cell and vascular function in health and disease," Antioxidants and Redox Signaling, vol. 6, no. 6, pp. 992-999, 2004.